Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $789.88 million. The enterprise value is $445.58 million.

Market Cap	789.88M
Enterprise Value	445.58M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

PLRX has 60.85 million shares outstanding. The number of shares has increased by 7.77% in one year.

Current Share Class	60.85M
Shares Outstanding	60.85M
Shares Change (YoY)	+7.77%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	2.87%
Owned by Institutions (%)	85.79%
Float	46.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	185.16
PB Ratio	2.28
P/TBV Ratio	2.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.26, with a Debt / Equity ratio of 0.17.

Current Ratio	10.26
Quick Ratio	10.18
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-88.44

Financial Efficiency

Return on equity (ROE) is -47.52% and return on invested capital (ROIC) is -30.14%.

Return on Equity (ROE)	-47.52%
Return on Assets (ROA)	-28.15%
Return on Capital (ROIC)	-30.14%
Revenue Per Employee	n/a
Profits Per Employee	-$1.28M
Employee Count	158
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.20% in the last 52 weeks. The beta is 1.09, so PLRX's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-8.20%
50-Day Moving Average	13.11
200-Day Moving Average	13.36
Relative Strength Index (RSI)	44.30
Average Volume (20 Days)	499,983

Short Selling Information

The latest short interest is 7.22 million, so 11.86% of the outstanding shares have been sold short.

Short Interest	7.22M
Short Previous Month	6.95M
Short % of Shares Out	11.86%
Short % of Float	15.41%
Short Ratio (days to cover)	17.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-222.08M
Pretax Income	-185.41M
Net Income	-201.68M
EBITDA	-219.95M
EBIT	-222.08M
Earnings Per Share (EPS)	-$3.34

Full Income Statement

Balance Sheet

The company has $404.51 million in cash and $60.21 million in debt, giving a net cash position of $344.30 million or $5.66 per share.

Cash & Cash Equivalents	404.51M
Total Debt	60.21M
Net Cash	344.30M
Net Cash Per Share	$5.66
Equity (Book Value)	345.82M
Book Value Per Share	5.68
Working Capital	370.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$132.94 million and capital expenditures -$3.70 million, giving a free cash flow of -$136.64 million.

Operating Cash Flow	-132.94M
Capital Expenditures	-3.70M
Free Cash Flow	-136.64M
FCF Per Share	-$2.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.77%
Shareholder Yield	-7.77%
Earnings Yield	-25.53%
FCF Yield	-17.30%

Analyst Forecast

The average price target for PLRX is $40.50, which is 212.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.50
Price Target Difference	212.02%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	154.75%
EPS Growth Forecast (5Y)	-8.66%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PLRX has an Altman Z-Score of 2.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.43
Piotroski F-Score	1